Hans Vink, PhD: The Endothelial Glycocalyx

Conference presentation · Boston 2026

The endothelial glycocalyx: from hemodynamic hypothesis to clinical risk predictor

Hans Vink, PhD, Co-Founder and Director of Advanced Research, GlycoCalyx Research Institute. Presented for the Translational Longevity Summit, Boston, October 2026.

  • 50 minutes
  • Slides with narration
  • Hans Vink and Bob Long

About this presentation

Hans Vink, PhD traces the endothelial glycocalyx from the first laboratory observations of the layer that lines every blood vessel to the way it is measured in people today. The talk follows the research in the order it happened: the early microcirculation experiments, how the glycocalyx was made visible and measured, what was learned about how it is damaged, and the clinical studies that examine glycocalyx measurements alongside cardiovascular outcomes.

The presentation was prepared with Bob Long and recorded by Boston BioLife, organizers of the Translational Longevity Summit.

This recording is a scientific presentation shared for educational purposes. It is not medical advice.